Syndax Pharmaceuticals (SNDX) Stock
Syndax Pharmaceuticals (SNDX) closed at $9.13 on Nov 16, 2026; its Tenet Score is 49 of 100 against 313 Healthcare peers.
32 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $9.13
- Nov 16, 2026
- Market cap
- $843.9M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 9.11 – 25.59
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 49/100
- Mixed · 313 Healthcare peers
Industry: Drugs
Syndax Pharmaceuticals Inc scores 49/100. Mixed. Strongest on financial health, quality is the soft spot versus 313 Healthcare peers. Insufficient inputs: Tenet 49 is built from 3 of 4 pillars, from 45% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=313Factor grades
Value omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mix…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Omeros CorporationOMER | 52 | $1.3B |
| Amphastar Pharmaceuticals IncAMPH | 67 | $1.3B |
| Opko Health IncOPK | 43 | $1.2B |
| Cronos Group IncCRON | 71 | $1.2B |
| Harrow IncHROW | 30 | $1.1B |
| Verastem IncVSTM | 18 | $1.0B |
| Savara IncSVRA | 32 | $1.0B |
| Janux Therapeutics IncJANX | 74 | $695.7M |
| Universe Pharmaceuticals INCUPC | 62 | $688.4M |
| Cullinan Therapeutics IncCGEM | 55 | $667.4M |
Common questions
What sector and industry is Syndax Pharmaceuticals in?
Syndax Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Syndax Pharmaceuticals' Tenet Score?
Syndax Pharmaceuticals' Tenet Score is 49 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




